Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gasperini

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
Neurology|March 4, 1998
Effect of steroids on Gd-enhancing lesions before and during recombinant beta interferon 1a treatment in relapsing remitting multiple sclerosisC Gasperini, C Pozzilli, S Bastianello, et al.
Neurology|January 27, 1998
Effect of training and different measurement strategies on the reproducibility of brain MRI lesion load measurements in multiple sclerosisM Filippi, M L Gawne-Cain, C Gasperini, et al.
Journal of the Neurological Sciences|October 20, 1999
Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1bG Antonelli, E Simeoni, F Bagnato, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 1, 1995
A controlled study of potential risk factors preceding exacerbation in multiple sclerosisC Gasperini, M G Grasso, M Fiorelli, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 1997
Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosisT Koudriavtseva, A J Thompson, M Fiorelli, et al.
European Journal of Neurology|November 28, 2002
A 6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with Interferon-betaA Paolillo, C Pozzilli, E Giugni, et al.
European Journal of Neurology|June 20, 2020
Efficacy of levetiracetam on upper limb movement in multiple sclerosis patients with cerebellar signs: a multicenter double-blind, placebo-controlled, crossover studyC Solaro, A de Sire, M Messmer Uccelli, et al.
AJNR. American Journal of Neuroradiology|January 5, 1999
Sensitivity of enhanced MR in multiple sclerosis: effects of contrast dose and magnetization transfer contrastS Bastianello, C Gasperini, A Paolillo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 20, 2011
Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) studyF Patti, M P Amato, M Trojano, et al.
AJNR. American Journal of Neuroradiology|January 22, 2021
Tailored Vessel-Catheter Diameter Ratio in a Direct Aspiration First-Pass Technique: Is It a Matter of Caliber?E Pampana, S Fabiano, G De Rubeis, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
Neurology|March 4, 1998
Effect of steroids on Gd-enhancing lesions before and during recombinant beta interferon 1a treatment in relapsing remitting multiple sclerosisC Gasperini, C Pozzilli, S Bastianello, et al.
Neurology|January 27, 1998
Effect of training and different measurement strategies on the reproducibility of brain MRI lesion load measurements in multiple sclerosisM Filippi, M L Gawne-Cain, C Gasperini, et al.
Journal of the Neurological Sciences|October 20, 1999
Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1bG Antonelli, E Simeoni, F Bagnato, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 1, 1995
A controlled study of potential risk factors preceding exacerbation in multiple sclerosisC Gasperini, M G Grasso, M Fiorelli, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 1997
Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosisT Koudriavtseva, A J Thompson, M Fiorelli, et al.
European Journal of Neurology|November 28, 2002
A 6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with Interferon-betaA Paolillo, C Pozzilli, E Giugni, et al.
European Journal of Neurology|June 20, 2020
Efficacy of levetiracetam on upper limb movement in multiple sclerosis patients with cerebellar signs: a multicenter double-blind, placebo-controlled, crossover studyC Solaro, A de Sire, M Messmer Uccelli, et al.
AJNR. American Journal of Neuroradiology|January 5, 1999
Sensitivity of enhanced MR in multiple sclerosis: effects of contrast dose and magnetization transfer contrastS Bastianello, C Gasperini, A Paolillo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 20, 2011
Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) studyF Patti, M P Amato, M Trojano, et al.
AJNR. American Journal of Neuroradiology|January 22, 2021
Tailored Vessel-Catheter Diameter Ratio in a Direct Aspiration First-Pass Technique: Is It a Matter of Caliber?E Pampana, S Fabiano, G De Rubeis, et al.
Pageof 10